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Abstract
Background: Seaweeds or marine algae have long been made up a key part of the Asian diet, and as an
antioxidant, sulphated polysaccharides have piqued the interest of many researchers as one of the ocean's
greatest treasures. The present investigation suggests the therapeutic potential of sulphated
polysaccharides from marine brown algae "Sargassum wightii" in Cyclosporine A (CsA)- induced liver injury.
CsA is a potent immunosuppressive agent used in the field of organ transplantations and various
autoimmune disorders. However, hepatotoxicity due to CsA remains to be one of the major clinical
challenges.
Methods: The effect of sulphated polysaccharides on CsA-induced hepatotoxicity was studied in adult
male albino rats of Wistar strain, and the animals were randomized into four groups with six rats in each.
Group I served as vehicle control. Group II rats were given CsA at a dosage of 25 mg/kg body weight,
orally for 21 days. Group III rats were given sulphated polysaccharides at a dosage of 5 mg/kg body weight,
subcutaneously for 21 days. Group IV rats were given sulphated polysaccharides simultaneously along with
CsA, as mentioned in Group II for 21 days.
Results: CsA provoked hepatotoxicity was evident from the decreased activities of hepatic marker
enzymes. A significant rise in the level of oxidants, along with a striking decline in both the enzymic and
non-enzymic antioxidants, marks the severity of oxidative stress in CsA-induced rats. This in turn led to
enhanced levels of lipid peroxidation, 8-hydroxy-2-deoxy guanosine and protein carbonyls, along with a
decrease in ATPase activities and alterations in lipid profile. Histopathological changes also strongly
support the above aberrations. However, concomitant treatment with sulphated polysaccharides restored
the above deformities to near control and prevented the morphological alterations significantly.
Conclusion: Thus, the present study highlights that sulphated polysaccharides can act therapeutically
against CsA-induced hepatotoxicity.
Key Words: Cyclosporine A; hepatic markers; antioxidants; hyperlipidemia; macromolecules; sulphated
polysaccharides.
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Background
The brown algae harvested from the earth's ocean are truly
one of the most valuable gifts of the great deep. Sargassum
wightii is one of the marine brown algal species widely
found in India, with tremendous biological applications
and are known to be rich in sulphated polysaccharides
content. Sulphated polysaccharides were found to possess
wide pharmacological actions, especially potent free radi-
cal scavenging [1] and antioxidant [2] effects. Further-
more, Raghavendran et al. [3] have documented that the
hot water extract of Sargassum polycystum was proved to be
an effective hepatoprotective agent against acetami-
nophen-induced liver damage. Further, Wong et al. [4]
have tested the effects of three seaweeds, and found that
Sargassum henslowianum exhibited significant protection
against carbon tetrachloride-induced liver injury in rats,
by reducing the acute increase of glutamate oxaloacetate
transaminase (GOT) and glutamate pyruvate transami-
nase (GPT) levels.
The introduction of Cyclosporine A (CsA) to the trans-
plant community had great significance, primarily
because of the improved graft survival rates with corre-
sponding decrease in rate of rejection episodes, due to its
immunosuppressive action. CsA also finds application in
the management of various autoimmune diseases. How-
ever, its clinical and experimental use is hampered by sev-
eral side effects, among which, hepatotoxicity is also one
of the most disquieting side effects [5]. Cholestasis, hyper-
bilirubinemia, hypoproteinemia, increased alkaline phos-
phatase and transaminases activities, bile salts in the
blood, inhibition of protein synthesis and disturbed lipid
secretion in both human and experimental animals was
found to characterize CsA-induced hepatotoxicity [5,6].
Additionally, alterations in bile formation, the capacity of
the liver to excrete organic anions and xenobiotics and
changes in the hepatic content of glutathione (GSH) was
also prominent in CsA provoked liver damage [7].
Although, various mechanisms for CsA-induced hepato-
toxicity have been proposed, the precise molecular mech-
anism still remains a matter of disagreement.
Nevertheless, numerous current findings suggest that reac-
tive oxygen species (ROS) production, oxidative stress,
depletion of hepatic antioxidant system and increase in
malondialdehyde (MDA) are the possible mechanisms of
CsA-induced hepatotoxicity [8].
Further, there are evidences suggesting that antioxidants
could play a beneficial role in CsA- induced hepatotoxic-
ity. It has been demonstrated that the hepatoprotective
activity of the marine algal extracts may also possibly due
to their antioxidant properties; acting as scavengers of free
radicals such as superoxide and alkoxy radicals [9]. Hence,
these findings created a background and interested us to
test whether the administration of sulphated polysaccha-
rides from Sargassum wightii could have any role on CsA-
induced hepatotoxicity.
Methods
Drugs and Chemicals
Cyclosporine A (CsA) was procured from Sandoz Ltd,
Basel, Switzerland. Bovine serum albumin and 1, 1', 3, 3'-
tetraethoxypropane were obtained from Sigma Chemi-
cals, St. Louis, MO, USA. All other chemicals and solvents
used were of analytical grade.
Seaweed collections and processing
The marine brown algal species Sargassum wightii was col-
lected from Mandapam, Gulf of Mannar region, Ram-
eswaram, India. The seaweed sample was washed in
seawater and fresh water thoroughly to remove the con-
tamination. The sample was then air dried in shade and
coarsely powdered and used for the further isolation pro-
cedure. The extraction procedure was carried out accord-
ing to the method of Vieira et al. [10], as previously
described [11]. Our earlier report [12] suggests that the
sulphated polysaccharides extracted from Sargassum
wightii  contain the following components: Total sugar
(69.26%), protein (3.01%), uronic acid (15.62%), sul-
phate (12.09%) and sulphated glycosaminoglycans
(74.21%).
Animal model
Adult male albino rats of Wistar strain (180 ± 20 g) were
purchased from Tamil Nadu Veterinary and Animal Sci-
ences University, Chennai, India. The animals were main-
tained under standard conditions of humidity,
temperature (25 ± 2°C) and 12 h light/12 h dark phases.
They were fed standard rat pelleted diet (M/s Pranav Agro
Industries Ltd., India) under the trade name Amrut rat/
mice feed and had free access to water. Experimental ani-
mals were handled according to the University and Insti-
tutional Legislation, regulated by the committee for the
purpose of Control and Supervision of Experiments on
Animals (CPCSEA), Ministry of Social Justice and
Empowerment, Government of India (IAES No. 02/052a/
06).
The animals were divided into four groups of six rats each
as follows. Group I served as olive oil treated vehicle con-
trol. Group II were administered CsA (25 mg/kg body
weight, orally) for 21 days. Group III were given sulphated
polysaccharides (5 mg/kg body weight, subcutaneously)
for 21 days as drug control. Group IV rats were treated
with sulphated polysaccharides (5 mg/kg body weight)
concomitantly along with CsA induction (25 mg/kg body
weight) for 21 days.
At the end of the experimental period, all the animals
were sacrificed by cervical decapitation. Liver tissues wereBMC Pharmacology 2008, 8:4 http://www.biomedcentral.com/1471-2210/8/4
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immediately excised and rinsed in ice-cold physiological
saline. The tissues were homogenized in 0.01 M Tris-HCl
buffer, pH 7.4. Aliquots of the tissue homogenate were
suitably processed for the assessment of following bio-
chemical parameters; also a section was set aside for his-
tological processing.
Biochemical assays
Aspartate aminotransferase (AST) and alanine ami-
notransferase (ALT) were assayed in the liver and their
activities were expressed in terms of μmoles of pyruvate
liberated/min/mg protein at 37°C [13]. Alkaline phos-
phatase (ALP) activity was estimated by using the stand-
ard protocol [14] and the enzyme activity was expressed in
terms of μmoles of phenol liberated/min/mg protein.
Activity of lactate dehydrogenase (LDH) was determined
by using the standardized procedure [15]. Protein content
was monitored by the method of Lowry et al. [16].
Evaluation of oxidative stress and hepatic antioxidant 
status
Oxidants generation in hepatic tissue was assessed using
the fluorescent probe, 2', 7' – dichlorodihydrofluorescein-
diacetate (DCFH-DA) [17]. The enzyme superoxide dis-
mutase (SOD) was assayed according to the method of
Marklund and Marklund [18]. The unit of enzyme activity
is defined as the amount of enzyme required to give 50%
inhibition of pyrogallol auto-oxidation. The activity of
catalase (CAT) in the tissue homogenate was assessed by
the method of Sinha [19]. Glutathione peroxidase (GPX)
was assayed according to the method of Rotruck et al. [20]
and its activity was assessed in terms of utilization of glu-
tathione. Total reduced glutathione (GSH) was estimated
by the method of Moron et al. [21]. This method was
based on the reaction of reduced glutathione with 5,
5'dithio-bis (2-nitrobenzoic acid) (DTNB) to give a com-
pound that absorbs at 412 nm. Vitamin C was assayed by
the procedure of Omaye et al. [22] and Vitamin E was
quantified in the tissues using the method of Desai et al.
[23].
Assessment of cellular macromolecular damage
Lipid peroxidation (LPO) in the liver tissue was deter-
mined by the method of Hogberg et al. [24]. Malondial-
dehyde (MDA), formed as an end product of the
peroxidation of lipids, served as an index of the intensity
of oxidative stress. MDA reacts with thiobarbituric acid to
generate a coloured product, which absorbs at 532 nm.
8-hydroxy-2-deoxyguanosine (8-OHdG) was quantified
by High performance liquid chromatography (HPLC)
using the standardized procedure [25]. Initially, the
nuclear DNA was isolated from the liver by the method of
Gross-Bellard et al. [26]. DNA thus isolated was dissolved
in 20 mM acetate buffer (pH 5.0) and digested to deoxy-
nucleosides with nuclease P1 and with alkaline phos-
phatase at 37°C for 1 h in 0.1 M Tris-HCl buffer (pH 7.5).
This was then followed by the injection of the deoxynucl-
eosides onto a C18 column equipped with both UV and
electrochemical detectors. The level of 8-OHdG was deter-
mined based on the peak height of authentic 8-OHdG
with electrochemical detector and the UV absorbance at
254 nm.
Protein carbonyl content in the tissue homogenate was
determined by the method based on the reaction of carb-
onyl groups with 2, 4-dinitrophenyl hydrazine (DNPH)
to form 2, 4-dinitrophenylhydrazone [27].
Assessment of tissue membrane integrity
Na+, K+-Adenosine triphosphatase (Na+, K+-ATPase) was
estimated by the method of Bonting [28]. The method of
Hjerten and Pan [29] and Ohnishi et al. [30] was followed
for the assay of Ca2+-Adenosine triphosphatase (Ca2+-
ATPase) and Mg2+-Adenosine triphosphatase (Mg2+-
ATPase). The amount of phosphorus liberated was deter-
mined by the method of Fiske and Subbarow [31].
Enzymic activities were expressed as μmoles of Pi liber-
ated/min/mg protein.
Analysis of lipid profile
Lipids were extracted from the liver tissues according to
the method of Folch et al. [32] using chloroform-metha-
nol mixture (2:1 v/v). Cholesterol estimation was done by
the method of Parekh and Jung [33] using ferric acetate –
uranyl acetate as the chromogenic reagent. Phospholipids
were determined by the method of Rouser et al. [34]. Trig-
lycerides and free fatty acid were quantified colorimetri-
cally [35,36].
Histopathological analysis
A portion of the liver tissue, immediately after sacrifice
was kept in 10% formalin to fix the tissue. The tissues
were washed in running tap water, dehydrated in the
descending grades of isopropanol and finally cleared in
xylene. The tissues were then embedded in molten paraf-
fin wax. Sections were cut at 10 μm thickness, stained with
haematoxylin and eosin. The sections were then viewed
under light microscope for histopthological changes.
Statistical analysis
The values are expressed as mean ± standard deviation
(S.D) for six animals in each group. Differences between
groups were assessed by one-way analysis of variance
(ANOVA) using SPSS software package for Windows. Post
hoc testing was performed for inter-group comparisons
using the least significance difference (LSD) test; signifi-
cance at p-value (<0.001, <0.01, < 0.05) have been given
respective symbols in the tables and figures.BMC Pharmacology 2008, 8:4 http://www.biomedcentral.com/1471-2210/8/4
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Results
Hepatic marker enzymes
Induction of CsA provoked severe biochemical amend-
ments as well as oxidative imbalance in hepatic tissues.
Table 1 displays the abnormally declined activities of
hepatic enzymes that serve as a hallmark of liver damage
provoked by CsA. Activities of these marker enzymes were
almost restored to near control values (P < 0.001 and P <
0.01) by sulphated polysaccharides co-administration.
Oxidative stress and its impact on macromolecules
Figure 1 portrays the extent of oxidants generation during
CsA administration and the protective effect of sulphated
polysaccharides in reducing the level of oxidants. Table 2
presents the status of antioxidant defense system. Statisti-
cally significant (P < 0.001 and P < 0.01) decrease in the
activities of antioxidant enzymes (SOD, CAT and GPx)
and the level of non-enzymic antioxidants (GSH, vitamin
C and vitamin E) were observed in CsA induced Group II
animals. This enzyme inhibition was markedly prevented
upon concomitant administration of sulphated polysac-
charides (SOD – 1.31-fold, CAT – 1.27-fold, GPx – 1.46-
fold) and improved the non-enzymic antioxidants level
(GSH – 1.31-fold, Vitamin C – 1.33-fold, Vitamin E –
1.41-fold) in the CsA given animals. The inhibition of oxi-
dants production and restoration of enzymic and non-
enzymic antioxidant status within control limits by sul-
phated polysaccharides indicates its potent antioxidant
effect against oxidative stress induced by CsA.
Table 3 delineates the levels of LPO, 8-OHdG and protein
carbonyls in the control and experimental animals. The
hepatic tissue of CsA treated rats showed a remarkable
increase in LPO, 8-OHdG and protein carbonyls, when
compared with the control. Concomitant treatment of
rats with sulphated polysaccharides significantly (P  <
0.001) reduced the elevated levels of LPO, 8-OHdG and
protein carbonyl close to that of controls, thereby strongly
confirming its potential in inhibiting the oxidation of
macromolecules like lipids, DNA and proteins.
Membrane integrity and altered lipid profile
Figure 2 indicates the effect of CsA and sulphated polysac-
charides on ATPases activity. A significant drop in the
activities of Na+ K+-ATPase, Ca2+-ATPase and Mg2+-ATPase
by 30.86%, 28.77% and 36.21% were noted in the
hepatic tissue of CsA given rats. Sulphated polysaccha-
rides co-administration restored the activities of these
ATPases near to that of controls, thereby showing its ben-
eficial effect in maintaining the membrane integrity.
Table 4 shows the level of lipid profile in the hepatic tissue
of CsA induced and sulphated polysaccharides treated
groups. Simultaneous treatment of CsA-induced rats with
sulphated polysaccharides favourably modulated the
lipid alterations, thereby proving its hypolipidemic activ-
ity.
Morphological changes
Histopathological findings in liver sections (H & E, 100×)
from the four experimental groups are highlighted in Fig-
ure 3. Control and drug control groups showed normal
liver architecture (Figures 3a and 3c). Liver sections
treated with CsA produced marked changes like inflam-
mation around portal triad (Triaditis) with patchy micro-
vesicular fatty degeneration (Figure 3b). Sulphated
polysaccharides treated Group IV rats (Figure 3d) showed
considerable reduction in the pathological changes as
seen in CsA induced animals and exhibited almost nor-
mal architecture as that of controls.
Discussion
Numerous evidences suggest that CsA-induced oxidative
stress is more associated with biochemical changes that
contribute to liver toxicity. It has also been reported that
CsA induction results in oxidative phosphorylation
uncoupling that in turn leads to the enhanced generation
of free radicals [37]. Hence the role of oxidative stress has
been strongly documented in the pathogenesis of CsA-
induced hepatotoxicity. The present study is the first
reported study of the protective role of sulphated polysac-
charides on CsA-induced hepatotoxicity.
Table 1: Effect of CsA and sulphated polysaccharides on hepatic marker enzymes
Enzyme parameters Group I (Control) Group II (CsA) Group III (Sulphated polysaccharides) Group IV (CsA + sulphated polysaccharides)
AST 0.22 ± 0.02 0.14 ± 0.01 a*** 0.23 ± 0.03 0.19 ± 0.02 a*b***
ALT 0.18 ± 0.02 0.09 ± 0.01 a*** 0.17 ± 0.02 0.15 ± 0.02 a*b***
LDH 11.57 ± 1.40 6.83 ± 0.75 a*** 11.52 ± 1.13 10.22 ± 1.23 b***
ALP 1.58 ± 0.19 1.25 ± 0.15 a** 1.60 ± 0.19 1.54 ± 0.15 b**
Values are expressed as mean ± S.D. for six animals in each group.
Units: AST, ALT – μmoles × 10-2 of pyruvate liberated/min/mg protein; LDH – μmoles × 10-1 of pyruvate liberated/min/mg protein; ALP – μmoles × 
10-2 of phenol liberated/min/mg protein.
Comparisons are made between: a – Group I and Groups II, III, IV; b – Group II and Group IV. The symbols (***), (**) and (*) represent statistical 
significance at P < 0.001, P < 0.01 and P < 0.05, respectively.BMC Pharmacology 2008, 8:4 http://www.biomedcentral.com/1471-2210/8/4
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In the present study, the animals treated with CsA showed
a significant liver damage, as elicited by the decreased
activities of hepatic marker enzymes (AST, ALT, ALP and
LDH). Decline in the activities of these hepatic enzymes
also serve as an indicator of altered cell membrane perme-
ability. It has been reported that when the liver is dam-
aged with the introduction of infectious agents or
chemicals, a significant increase in the levels of GOT and
GPT were seen in the serum [38], and this increase has
been attributed to damage to the structural integrity of the
liver. Moreover, it has been well established that CsA
administration causes a marked elevation in the activities
of aminotransferases and alkaline phosphatase during
hepatotoxicity [5,6], which strongly supports our present
observation. LDH is the main regulator of many biochem-
ical reactions in the body and fluids. The present study
also shows a significant decrease in the activity of LDH,
indicating the extent of liver damage. Administration of
sulphated polysaccharides restored the activities of
hepatic marker enzymes to a considerable extent. This
protective action might possibly be due to its effect of pre-
serving the cellular membrane of the hepatocytes from
breakage by the reactive metabolites. Raghavendran et al.
[3] have documented that the alcoholic extract of the sea-
weed  Sargassum polycystum showed a potent beneficial
effect against acetaminophen induced oxidative liver
damage, by protecting the liver marker enzymes as well as
by strengthening the antioxidant defense system.
Further, increased oxidants production in CsA-induced
liver tissue was evident from DCFH oxidation. The oxida-
tion of DCFH to the fluorescent compound DCF was con-
sidered to be a comparatively specific indicator of
oxidants generation. Enormous reports suggest that ROS
production, oxidative stress, depletion of hepatic antioxi-
dant system and increase in MDA are the possible mecha-
nisms of CsA-induced hepatotoxicity [8]. Sulphated
polysaccharides co-administration minimized the oxi-
dants production by scavenging the free radicals. Moreo-
ver, Park et al. [1] have documented that the extract from
Sargassum species exerts potent free radical scavenging
activity, thereby emphasizing its antioxidant potential.
It has been found that a powerful and potent endogenous
antioxidant defense system functions to battle free radi-
cals. Antioxidant enzymes such as SOD, CAT and GPX
comprise a major supportive group of protection against
free radicals. In the present investigation, a striking
decrease in the activities of these antioxidant enzymes in
CsA exposed rats elicits strong evidence for the involve-
Table 2: Effect of CsA and sulphated polysaccharides on the antioxidant defense system in the hepatic tissues
Antioxidants Group I (Control) Group II (CsA) Group III (Sulphated polysaccharides) Group IV (CsA + sulphated polysaccharides)
Enzymic antioxidants
SOD 8.73 ± 0.96 6.52 ± 0.79 a*** 8.75 ± 0.87 8.54 ± 0.94 b***
CAT 342.67 ± 41.40 260.50 ± 28.63 a*** 341.92 ± 41.31 329.84 ± 32.65 b**
GPx 18.76 ± 1.86 12.38 ± 1.63 a*** 19.01 ± 2.09 18.12 ± 1.79b***
Non-enzymic antioxidants
GSH 16.89 ± 1.86 12.53 ± 1.24 a*** 16.82 ± 2.00 16.47 ± 1.81 b***
Vitamin C 1.92 ± 0.21 1.26 ± 0.15 a*** 1.96 ± 0.19 1.67 ± 0.20 a*b**
Vitamin E 0.84 ± 0.08 0.56 ± 0.07 a*** 0.89 ± 0.09 0.79 ± 0.08 b***
Values are expressed as mean ± S.D. for six animals in each group.
Units of enzyme activity: SOD: Units/mg protein, one unit is equal to the amount of enzyme that inhibits the auto-oxidation reaction by 50%; CAT: 
μmoles of H2O2 consumed/min/mg protein; GPx: μg of reduced GSH consumed/min/mg protein; GSH, vitamin C and vitamin E: μg/mg protein.
Comparisons are made between: a-Group I and Groups II, III, IV; b-Group II and Group IV. The symbols (***), (**) and (*) represent statistical 
significance at P < 0.001, P < 0.01 and P < 0.05, respectively.
Effect of CsA and sulphated polysaccharides on hepatic oxi- dants production Figure 1
Effect of CsA and sulphated polysaccharides on hepatic oxi-
dants production. Values are expressed as mean ± S.D. for 
six animals in each group. Group I – Control; Group II – 
CsA; Group III – Sulphated polysaccharides; Group IV – 
CsA+sulphated polysaccharides. Comparisons are made 
between: a-Group I and Groups II, III, IV; b-Group II and 
Group IV. The symbols (***) and (**) represent statistical sig-
nificance at P < 0.001 and P < 0.01, respectively.BMC Pharmacology 2008, 8:4 http://www.biomedcentral.com/1471-2210/8/4
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ment of oxidative damage in CsA-induced hepatotoxicity.
SOD prevents the inhibition of GPX and CAT by scaveng-
ing superoxide radicals and GPx and CAT in turn prevent
the inhibition of SOD by scavenging H2O2 [39]. Further,
a marked drop in GSH levels was more significantly noted
in CsA induced group. This is in line with the observation
by previous reporters [7], who found that CsA induction
showed a decrease in the total GSH content in the liver.
Non-enzymic antioxidants further support the protective
role of enzymic antioxidants, which was decreased after
CsA administration in the present study. Vitamin C acts as
the first line of defense in the aqueous compartment,
while vitamin E is a chain breaking antioxidant, present in
biological membranes. Further, the role of vitamins E and
C in repairing oxidative renal toxicity after CsA adminis-
tration has also been reported. Durak et al. [40] have doc-
umented that vitamins E and C combined treatment
produced an increase in antioxidant capacity of hepatic
tissue, which were very low in CsA treated animals.
Co-supplementation of sulphated polysaccharides was
found to alleviate the oxidative injury by enhancing the
antioxidant status. Sulphated polysaccharides also
afforded protection by recycling both ascorbate and the
membrane antioxidant vitamin E. The free radical scav-
enging activity of the brown algae have been tested by sev-
Effect of CsA and Sulphated polysaccharides on the activities of ATPases in the liver tissues Figure 2
Effect of CsA and Sulphated polysaccharides on the activities of ATPases in the liver tissues. Values are expressed 
as mean ± S.D. for six animals in each group. Units: Na+ K+-ATPase, Ca2+-ATPase and Mg2+-ATPase: μmole of inorganic phos-
phorous liberated/min/mg protein. Group I – Control; Group II – CsA; Group III – Sulphated polysaccharides; Group IV – 
CsA+sulphated polysaccharides Comparisons are made between: a-Group I and Group II, III, IV; b-Group II and Group IV. The 
symbols (***), (**) and (*) represent statistical significance at P < 0.001, P < 0.01 and P < 0.05, respectively.
Table 3: Effect of CsA and sulphated polysaccharides on the levels of LPO, 8-OHdG and protein carbonyls
Parameters Group I (Control) Group II (CsA) Group III (Sulphated polysaccharides) Group IV (CsA + sulphated polysaccharides)
LPO 1.42 ± 0.14 3.89 ± 0.43 a*** 1.38 ± 0.17 1.75 ± 0.17 a*b***
8-OHdG 11.59 ± 1.04 21.25 ± 3.24 a*** 11.48 ± 1.26 15.76 ± 2.25 a**b***
Protein carbonyls 1.76 ± 0.16 3.38 ± 0.41 a*** 1.73 ± 0.19 2.12 ± 0.26 a*b***
Values are expressed as mean ± S.D. for six animals in each group.
Units: LPO: nmoles of MDA formed/min/mg protein; 8-OHdG: fmoles of 8-OHdG/μg of nuclear DNA; Protein carbonyls: μg/mg protein.
Comparisons are made between: a-Group I and Groups II, III, IV; b-Group II and Group IV. The symbols (***), (**) and (*) represent statistical 
significance at P < 0.001, P < 0.01 and P < 0.05, respectively.BMC Pharmacology 2008, 8:4 http://www.biomedcentral.com/1471-2210/8/4
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eral authors and found that it could exhibit significant
antioxidant effect by remarkably scavenging superoxide
and hydroxyl radicals [41]. This possible reason can be
extended to the sulphated polysaccharides from Sargas-
sum wightii, in enhancing the antioxidant status during
CsA induction.
The data observed in the present study thus strongly con-
firms that CsA-induced hepatotoxicity is associated with
augmented oxidative stress. Cellular macromolecules are
the important targets of ROS and their oxidative products
exert diverse biological effects. This is evident from
increased LPO, 8-OHdG and protein carbonyls; hallmarks
of lipid, DNA and protein damage, in the CsA adminis-
tered Group II animals. Oxidative destruction of polyun-
saturated fatty acids (PUFA) initiates a self-perpetuating
chain reaction and generation of more free radicals in a
well-documented process termed, LPO, which results in
loss of PUFA, and decreased membrane fluidity. There is
also evidence showing that CsA increases ROS production
and the formation of Thiobarbituric acid reactive sub-
stances (TBARS) in rat-cultured hepatocytes [42]. ROS
also exerts adverse effects on DNA and protein by increas-
ing the formation of 8-OHdG and protein carbonyls. The
target of ROS attack could be either the sugar or the base
components of the DNA molecule, and the most com-
mon base modification induced by ROS is 8-OHdG [43],
which indicates DNA damage. Carbonyl content is meas-
ured as an index of protein oxidation [44], where the
amino acids are converted to carbonyl derivatives.
Increased protein oxidation was apparent from elevated
levels of protein carbonyls in the liver tissue of CsA
administered rats in the present study.
Sulphated polysaccharides co-supplementation signifi-
cantly prevented the oxidative damage to macromole-
cules, by minimizing the levels of LPO, 8-OHdG and
protein carbonyls. There is also evidence indicating that
polysaccharides inhibited LPO by showing that when
polysaccharides were present, the TBARS, indicative of
LPO had no apparent plateau, which indicates that the
formation of TBARS in the system was slowed apparently
by the polysaccharides [2]. Further, the protective effect of
sulphated polysaccharides against DNA damage can be
positively correlated with the study of Ishikawa and Kita-
mura [45], which showed that heparin effectively prevents
nuclear condensation and fragmentation and DNA frag-
mentation. These observations strongly support our study
that sulphated polysaccharides could potentially inhibit
cellular macromolecular damages.
It is a well-established fact that the permeability of cell
membranes to various ions depends on its lipid constitu-
ents. Lipids are an essential assembly of compounds
implicated in cellular function, rendering substantial con-
tribution to the surface properties of the cell. The
increased cardiovascular risk profile as a result of CsA
Histopathological findings in the liver tissue of CsA-induced  and treated groups Figure 3
Histopathological findings in the liver tissue of CsA-induced 
and treated groups. Control and drug control groups show 
normal liver architecture (Figure 3a and 3c). Liver sections 
treated with CsA produces marked changes like inflamma-
tion around portal triad (Triaditis) with patchy microvesicu-
lar fatty degeneration (Figure 3b). Sulphated polysaccharides 
treated rats (Figure 3d) show considerable reduction in the 
pathological changes compared to CsA-induced animals.
Table 4: Effect of CsA and sulphated polysaccharides on lipid profile
Lipid profile (mg/g wet tissue) Group I (Control) Group II (CsA) Group III (Sulphated 
polysaccharides)
Group IV (CsA + sulphated 
polysaccharides)
Total cholesterol 5.87 ± 0.71 8.01 ± 1.22 a*** 5.79 ± 0.76 6.22 ± 1.01 b**
Phospholipids 20.52 ± 2.93 14.63 ± 1.93 a*** 20.59 ± 3.14 19.21 ± 1.72 b**
Triglycerides 7.93 ± 0.87 10.25 ± 1.67 a** 7.90 ± 1.05 8.21 ± 1.17 b**
Free fatty acids 3.32 ± 0.44 4.26 ± 0.65 a** 3.33 ± 0.30 3.56 ± 0.39 b*
Values are expressed as mean ± S.D. for six animals in each group.
Comparisons are made between: a-Group I and Groups II, III, IV; b-Group II and Group IV. The symbols (***), (**) and (*) represent statistical 
significance at P < 0.001, P < 0.01 and P < 0.05, respectively.BMC Pharmacology 2008, 8:4 http://www.biomedcentral.com/1471-2210/8/4
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administration is ascribed to both a quantitative increase
in LDL particles and an increased oxidizability of the LDL
particles [46]. Hence, knowledge of the interaction
between CSA and lipid membranes is central to under-
standing the mechanism of its toxicity. In the present
study, increase in the level of total cholesterol, triglycer-
ides and free fatty acid in the hepatic tissue of CsA-
induced rats indicates that CsA treatment might also raises
the jeopardy of atherosclerosis. Princen et al. [47] have
reported that there is a marked down-regulation in the
activity of hepatic cholesterol 7 α-hydroxylase during CsA
treatment, which might be the possible reason for the so
found increased level of total cholesterol in the liver.
Since, this enzyme is the rate-limiting step in cholesterol
conversion to bile acid (prime pathway of cholesterol
catabolism), its down-regulation by CsA therapy can lead
to the accumulation of cholesterol. Phospholipids are the
crucial structural components of animal cell membrane
and cytoskeleton. Our data showed a decrease in tissue
phospholipid content, which might be due to the
increased activity of phospholipases. Further, elevations
in the level of tissue triglycerides and free fatty acids indi-
cate the liver injury due to altered lipid composition. On
the other hand, co-treatment of rats with sulphated
polysaccharides reduced the increased accumulation of
total cholesterol and favourably modulated the lipid pro-
files. Enormous evidences support our observation,
wherein sulphated polysaccharides from brown algae
exhibit anti-hyperlipidemic effect [48], which strengthens
the present observation of sulphated polysaccharides as
an anti-hyperlipidemic agent.
Enhanced damages on the membrane are further evident
from altered ATPases activities in the liver tissue of CsA
administered groups. CsA-induced peroxidation of mem-
brane lipids was coupled with significant inhibition of
membrane ATPases. Na+, K+-ATPase is widely considered
to be the enzyme system of the plasma membrane respon-
sible for the active transport of Na+ and K+. Ca2+-ATPase is
responsible for the fine-tuning of intracellular calcium.
Mg2+-ATPase also plays a role in endergonic processes
other than ion transport. In the present study, reduction
in the activities of ATPases in CsA administered rats may
be due to the oxidation of membrane lipids and proteins.
Activities of these ATPases were remarkably brought back
to near control values with sulphated polysaccharides
treatment, thereby maintaining the membrane integrity.
Thus, sulphated polysaccharides by inhibiting the macro-
molecular oxidation, maintains the membrane integrity
and thereby safeguards the hepatic marker enzymes.
Hepatotoxicity induced by CsA is further confirmed by
abnormal histological findings. Toxicity manifestations
by CsA in the liver tissue are revealed by morphological
changes such as inflammation around portal triad (Triadi-
tis) with severe patchy microvesicular fatty degeneration.
Our results are in agreement with previous investigators
[49], who reported morphological changes, including dis-
organization of hepatic parenchyma with widespread cell
swelling and congestion of sinusoids during CsA adminis-
tration. These changes were not observed in the rats
treated with sulphated polysaccharides in Group IV ani-
mals, suggesting the protective role of sulphated polysac-
charides in attenuating CsA-induced morphological
changes.
Conclusion
CsA, though it remains as a gold standard as an immuno-
suppressant in the transplantation field, its hepatotoxic
effect remains to be one of the most tormenting side
effects. The present study indicates that CsA-induced
hepatotoxicity is associated with oxidative stress, cellular
macromolecular damages, altered lipid profile and mor-
phological changes. On the other hand, sulphated
polysaccharides from Sargassum wightii were found to
exhibit potent mitigating effect on oxidative liver injury
induced by CsA, through its antioxidant effect, thereby
signifying that sulphated polysaccharides can act as an
effective hepatoprotective agent, when simultaneously
given along with CsA treatment.
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